IUGNF
IMUGENE LTD ORD by Imugene, Ltd. (IUGNF)
$
02About IMUGENE LTD ORD by Imugene, Ltd. (IUGNF)
Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialization of immunotherapies against cancer. Its products include b-cell peptide cancer vaccines, arginine modulators, and mimotopes. The company was founded on May 30, 1986 and is headquartered in Sydney, Australia.
Details
Daily high
$0.02
Daily low
$0.02
Price at open
$0.02
52 Week High
$0.06
52 Week Low
$0.00
Market cap
149.3M
Dividend yield
0.00%
Volume
10,335
Avg. volume
155,012
P/E ratio
-1.72
IMUGENE LTD ORD by Imugene, Ltd. News
Details
Daily high
$0.02
Daily low
$0.02
Price at open
$0.02
52 Week High
$0.06
52 Week Low
$0.00
Market cap
149.3M
Dividend yield
0.00%
Volume
10,335
Avg. volume
155,012
P/E ratio
-1.72